TAUNS Laboratories (197A) · InitiativeFirst statedLatest Management Plan (2026-07-15): "Advanced"
Reducing Dependence on Specific Products Through New Products and Markets
First written in FY2024. 1 of 2 entries say "Advanced", first in 2026-07-15. Latest entry: 2026-07-15.
2entries
3years
1from disclosures
How it moved
Same theme, other companies
Expanding the customer base to mitigate customer and product concentrationA theme 43 companies write about · 1 as a headwind · 42 as a tailwind
20 other companies' latest entry also says "Advanced".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 43 companies compared. The sentences above are computed from all 43.Full recordFilings, disclosures and news, newest first
- 2026-07-15AdvancedManagement Plan
「Make new POCT, SaMD and contract testing new pillars of earnings.」
To reduce dependence on specific products, the company presented a plan to make new POCT, SaMD and contract testing, in addition to antigen tests, pillars of earnings. - FY2024First statedAnnual report
「We are continuously developing next-generation testing technologies and new products, exploring new markets, and working to expand revenue from products other than those related to COVID-19.」
Next-generation technologies, new products, new markets, regulatory initiatives, and optimization of the transition to mass production are being used to reduce revenue dependence.